In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus

Vaccine

Volumn 20, Issue 25-26, 2002, Pages 3095-3103

  Esumi, Mariko ^a   Zhou, Yi Hua ^a   Tanoue, Tetsuya ^b   Tomoguri, Tetsushi ^b   Hayasaka, Ikuo ^b  

^a NIHON UNIVERSITY   (Japan)

^b SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

Author keywords

Cross reactive antibody; Hepatitis C virus; Hypervariable region 1

Indexed keywords

ANTISERUM; CROSS REACTING ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HEPATITIS VACCINE; HVR1 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CARBOXY TERMINAL SEQUENCE; CHIMPANZEE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VIREMIA; VIRUS ADSORPTION; VIRUS CAPTURE ASSAY; VIRUS NEUTRALIZATION; VIRUS TITRATION; ACUTE DISEASE; ADSORPTION; AMINO ACID SEQUENCE; ANIMAL; CROSS REACTION; DRUG DESIGN; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; PAN TROGLODYTES; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SERODIAGNOSIS;

ACUTE DISEASE; ADSORPTION; AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; CROSS REACTIONS; DRUG DESIGN; EPITOPES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; MALE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PAN TROGLODYTES; RNA, VIRAL; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SUPPORT, NON-U.S. GOV'T; VIRAL HEPATITIS VACCINES; VIRAL PROTEINS; VIREMIA; ANIMALS;

EID: 0037135671     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00271-2     Document Type: Article

References (24)

1. Epidemiology of hepatitis C: Geographic differences and temporal trends
2. Efficacy of prophylactic γ-globulin in preventing non-A, non-B post-transfusion hepatitis
3. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis: Role of γ-globulin prophylaxis in its prevention
4. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients
5. Vaccination of chimpanzees against infection by the hepatitis C virus
6. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV
7. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
8. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
9. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees
10. Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1
11. Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response
12. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus
13. Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity
14. Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro
15. The serology of hepatitis C virus (HCV) infection: Antibody cross-reaction in the hypervariable region 1
16. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus
17. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization
18. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus
19. Comparison of amino acid sequences in hypervariable region 1 of hepatitis C virus clones between human inocula and the infected chimpanzee sera
20. Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample
21. Selective transmission of hepatitis C virus in vivo and in vitro
22. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures
23. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection
24. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro